tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZLAB Stock Latest News

Zai Lab to wait on results of FORTITUDE-102 prior to regulatory filing
The FlyZai Lab to wait on results of FORTITUDE-102 prior to regulatory filing
4d ago
AMGN
ZLAB
Zai Lab announces approval of TIVDAK in Hong Kong
PremiumThe Fly
Zai Lab announces approval of TIVDAK in Hong Kong
6d ago
ZLAB
Zai Lab Ltd’s Earnings Call Highlights Growth and Profitability Path
PremiumCompany Announcements
Zai Lab Ltd’s Earnings Call Highlights Growth and Profitability Path
26d ago
ZLAB
Zai Lab’s Growth Potential and Global Expansion: A Strong Buy Recommendation
PremiumRatings
Zai Lab’s Growth Potential and Global Expansion: A Strong Buy Recommendation
26d ago
ZLAB
Zai Lab price target raised to $69 from $66 at Citi
PremiumThe Fly
Zai Lab price target raised to $69 from $66 at Citi
27d ago
ZLAB
Zai Lab Reports Growth and Strategic Progress in Q2 2025
PremiumCompany AnnouncementsZai Lab Reports Growth and Strategic Progress in Q2 2025
1M ago
ZLAB
Zai Lab reports Q2 EPS (4c), consensus (42c)
Premium
The Fly
Zai Lab reports Q2 EPS (4c), consensus (42c)
1M ago
ZLAB
Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
Premium
Ratings
Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
2M ago
ZLAB
Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
PremiumRatings
Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
2M ago
ZLAB
Zai Lab price target raised to $75 from $73 at Leerink
PremiumThe Fly
Zai Lab price target raised to $75 from $73 at Leerink
2M ago
AMGN
ZLAB
Zai Lab announces FORTITUDE-101 clinical trial meets primary endpoint
PremiumThe Fly
Zai Lab announces FORTITUDE-101 clinical trial meets primary endpoint
2M ago
ZLAB
Zai Lab Shareholders Approve Key Proposals at AGM
PremiumCompany Announcements
Zai Lab Shareholders Approve Key Proposals at AGM
3M ago
8K
ZLAB
Zai Lab announces new data from preclinical study of ZL-1503
PremiumThe FlyZai Lab announces new data from preclinical study of ZL-1503
3M ago
ZLAB
Promising Oncology Developments and Strategic Insights Drive Buy Rating for Zai Lab
Premium
Ratings
Promising Oncology Developments and Strategic Insights Drive Buy Rating for Zai Lab
3M ago
ZLAB
Zai Lab presents updated data from Phase 1a/1b trial evaluating ZL-1310
Premium
The Fly
Zai Lab presents updated data from Phase 1a/1b trial evaluating ZL-1310
3M ago
ZLAB
Zai Lab receives FDA fast track designation for ZL-1310
PremiumThe Fly
Zai Lab receives FDA fast track designation for ZL-1310
4M ago
ZLAB
Zai Lab’s Growth Amidst Competitive Pressures: Analyst Recommends Hold
PremiumRatings
Zai Lab’s Growth Amidst Competitive Pressures: Analyst Recommends Hold
4M ago
ZLAB
Zai Lab Ltd’s Earnings Call Highlights Strong Growth and Promising Pipeline
PremiumCompany Announcements
Zai Lab Ltd’s Earnings Call Highlights Strong Growth and Promising Pipeline
4M ago
ZLAB
Zai Lab’s Promising Pipeline and Strategic Advancements Drive Positive Outlook Despite Q1 Revenue Miss
PremiumRatings
Zai Lab’s Promising Pipeline and Strategic Advancements Drive Positive Outlook Despite Q1 Revenue Miss
4M ago
ZLAB
Zai Lab’s Growth Potential: Strong Revenue Projections and Strategic Positioning Drive Buy Rating
PremiumRatingsZai Lab’s Growth Potential: Strong Revenue Projections and Strategic Positioning Drive Buy Rating
4M ago
ZLAB
Zai Lab: Hold Rating Amid Mixed Financial Performance and Cautious Outlook
Premium
Ratings
Zai Lab: Hold Rating Amid Mixed Financial Performance and Cautious Outlook
4M ago
ZLAB
Zai Lab Reports Strong Q1 2025 Financial Growth
Premium
Company Announcements
Zai Lab Reports Strong Q1 2025 Financial Growth
4M ago
ZLAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >